MarketInOut Stock Screener Log In | Sign Up
 

Bristol Myers Squibb Co

NYSE • Healthcare • Drug Manufacturers - General • Quote as of 08/14/2026
Bristol Myers Squibb Co stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNYSE
Market Capitalization130,121 mln
Float1,952 mln
Earnings Date10/29/2026

EPS

4.55
Solid

P / E

14.03
Fair value

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.73
Likely reliable

1-Year Forecast

66.21
Fairly priced

Relative Strength

13 / 100
Significantly lagging

Business Description

Founded in 1887 and based in Princeton, New Jersey, Bristol-Myers Squibb is a global biopharmaceutical company that researches, makes, and sells medicines across a wide range of serious health conditions, including cancer, blood disorders, heart disease, and autoimmune and neurological conditions. Its portfolio includes well-known treatments such as Opdivo, Yervoy, Eliquis, and Revlimid, among many others. The company distributes its products through wholesalers, pharmacies, hospitals, and government agencies around the world.

Key Fundamentals

EPS4.55
P/E14.03
ROE47.92
RPS24.07
ROIC14.07
ROA10.18
Interest Cover8.00
EBITDA, mln16,816
EV / EBITDA9.95
EV / EBIT12.27
Revenue, mln49,187
EV / Revenue3.40

Financial Strength

Altman Z-Score2.6
Piotroski F-Score 7 / 9
Beneish M-Score-2.73
1-Year Target Price66.21
Shiller PE Ratio38.37
Short Ratio4.76
Short % of Float2.56

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -1.38% 17 / 100   
1 Month 5.49% 76 / 100   
2 Months 14.74% 87 / 100   
6 Months 8.92% 61 / 100   
1 Year 39.76% 84 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us